Lawmakers respond to CMS Part B plan

Republicans and Democrats on the U.S. Senate Finance Committee sent acting CMS Administrator Andy Slavitt separate letters Thursday expressing concerns about the agency's planned overhaul of reimbursement for drugs administered under Medicare Part B. The letters, which reflect the views of oncologists and drug companies, are a strong rebuke for Slavitt and the proposed reimbursement policies.

As BioCentury reported Wednesday, the Republican (see BioCentury Extra, April 27). ...